ATRC AtriCure Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ATRC

Price (delayed)

$37.94

Market cap

$1.77B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.02

Enterprise value

$1.78B

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure ...

Highlights
ATRC's revenue is up by 20% year-on-year and by 4.7% since the previous quarter
The company's gross profit rose by 19% YoY and by 4.3% QoQ
ATRC's net income has shrunk by 193% YoY but it is up by 17% QoQ
AtriCure's EPS has plunged by 192% YoY but it has increased by 17% from the previous quarter
The equity has contracted by 6% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.atricure.com
Peers: TFX COO BSX EW

Key stats

What are the main financial stats of ATRC
Market
Shares outstanding
46.57M
Market cap
$1.77B
Enterprise value
$1.78B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.86
Price to sales (P/S)
5.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.4
Earnings
Revenue
$330.38M
EBIT
-$41.21M
EBITDA
-$29.5M
Free cash flow
-$39.02M
Per share
EPS
-$1.02
Free cash flow per share
-$0.85
Book value per share
$9.82
Revenue per share
$7.22
TBVPS
$6.81
Balance sheet
Total assets
$585.45M
Total liabilities
$128.69M
Debt
$74.55M
Equity
$456.75M
Working capital
$156.82M
Liquidity
Debt to equity
0.16
Current ratio
3.69
Quick ratio
2.81
Net debt/EBITDA
-0.56
Margins
EBITDA margin
-8.9%
Gross margin
74.4%
Net margin
-14.1%
Operating margin
-12.9%
Efficiency
Return on assets
-7.9%
Return on equity
-10.2%
Return on invested capital
-14.6%
Return on capital employed
-7.8%
Return on sales
-12.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATRC stock price

How has the AtriCure stock price performed over time
Intraday
-2.12%
1 week
-3.58%
1 month
-9.69%
1 year
-39.11%
YTD
-14.51%
QTD
-14.51%

Financial performance

How have AtriCure's revenue and profit performed over time
Revenue
$330.38M
Gross profit
$245.94M
Operating income
-$42.67M
Net income
-$46.47M
Gross margin
74.4%
Net margin
-14.1%
ATRC's net income has shrunk by 193% YoY but it is up by 17% QoQ
The net margin has plunged by 177% YoY but it has grown by 21% from the previous quarter
The operating margin has surged by 73% year-on-year and by 20% since the previous quarter
The operating income has soared by 67% YoY and by 16% from the previous quarter

Growth

What is AtriCure's growth rate over time

Valuation

What is AtriCure stock price valuation
P/E
N/A
P/B
3.86
P/S
5.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.4
AtriCure's EPS has plunged by 192% YoY but it has increased by 17% from the previous quarter
ATRC's price to book (P/B) is 28% lower than its 5-year quarterly average of 5.5 and 18% lower than its last 4 quarters average of 4.8
The equity has contracted by 6% YoY
ATRC's P/S is 30% below its 5-year quarterly average of 7.7 and 24% below its last 4 quarters average of 7.1
ATRC's revenue is up by 20% year-on-year and by 4.7% since the previous quarter

Efficiency

How efficient is AtriCure business performance
The ROE has plunged by 189% YoY but it has grown by 16% from the previous quarter
The company's return on invested capital has shrunk by 177% YoY but it rose by 17% QoQ
AtriCure's ROS has plunged by 162% YoY but it has increased by 23% from the previous quarter
AtriCure's return on assets has increased by 17% QoQ

Dividends

What is ATRC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATRC.

Financial health

How did AtriCure financials performed over time
The current ratio is up by 6% year-on-year
AtriCure's total assets has decreased by 4.9% YoY
The debt is 84% less than the equity
The debt to equity has declined by 6% since the previous quarter
The equity has contracted by 6% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.